The Safety and Effectiveness of NV-A01 in Glioma Patients
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn about the safety and effectiveness of NV-A01 in
the treatment of advanced glioma patients. The main questions it aims to answer are:
1. The safety of NV-A01 in the treatment of advanced glioblastoma patients.
2. The effectiveness of NV-A01 in treating patients with advanced glioblastoma.
Phase:
Phase 1
Details
Lead Sponsor:
First Affiliated Hospital of Wannan Medical College